Cryo-Cell International (CCEL) Financial Statements & Analysis

Cryo-Cell International (CCEL) Income Statement

Cryo-Cell International reported revenue of $31.57M in fiscal 2025 (fiscal year ended Nov 30, 2025), down 1.3% from $31.99M a year earlier. Cryo-Cell International posted a net loss of $2.43M, compared with net income of $402.10K a year earlier. Gross margin was 76.6% and operating margin 15.3%. In the most recent quarter, Q3 fiscal 2026 (ended Aug 31, 2026), revenue was $7.82M, flat from the same quarter a year earlier.

Cryo-Cell International Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cryo-Cell International, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Nov 2025	Feb 2025	Nov 2024	Nov 2023	Feb 2023	Nov 2022	Nov 2021	Nov 2020	Nov 2019	Nov 2018	Nov 2017
Revenue & Gross Profit
Revenue	31.57	31.99	31.99	31.34	30.34	30.34	28.88	31.15	31.82	29.22	25.38
Cost of Revenue	7.38	7.95	7.95	8.39	8.79	8.79	10.15	10.94	10.04	8.54	6.72
Gross Profit	24.19	24.04	24.04	22.95	21.54	21.54	19.90	20.21	21.78	20.68	18.66
Operating Expenses
Research & Development	0.38	1.24	1.24	1.17	0.38	0.38	0.05	0.02	0.03	0.09	0.04
Selling, General & Administrative	18.22	18.52	18.52	17.17	15.58	15.58	14.61	14.29	14.89	15.63	13.48
Operating Expenses	19.35	20.56	20.25	19.46	17.52	17.08	15.88	14.48	16.72	15.49	13.65
Operating Income	4.84	3.48	3.79	3.49	4.02	4.46	4.02	5.72	5.06	5.19	5.01
Other Income/Expense
Interest Income	0.00	0.00	0.11	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Interest Expense	2.07	1.86	1.86	1.24	1.52	1.52	-1.38	-1.54	1.70	1.55	1.30
Other Income/Expense	-7.18	-0.68	0.88	-15.62	-0.71	0.38	-1.41	0.00	-1.67	-1.57	-1.38
Income
Income Before Tax	-2.34	2.80	2.80	-13.36	3.32	3.32	2.61	5.04	3.39	3.62	3.62
Income Tax Expense	0.09	2.40	2.40	-3.84	0.55	0.55	0.53	1.41	1.10	4.47	1.31
Net Income	-2.43	0.40	0.40	-9.52	2.77	2.77	2.08	3.62	2.29	-0.85	2.32
Net Income - Continuous Operations	-2.43	0.40	0.40	-9.52	2.77	2.77	2.08	3.62	2.29	-0.85	2.32
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-
EBITDA	1.10	1.42	5.69	-10.42	6.65	6.65	4.27	6.09	5.50	5.48	5.16
EBIT	0.48	-	4.67	-12.13	-	4.84	3.24	5.72	-	-	-
Depreciation & Amortization	1.37	0.48	0.48	1.12	1.81	1.12	1.04	0.37	0.40	0.32	0.23
Earnings Per Share
Basic EPS	-	-	-	-1.00	-	-	-	-	-	-	-
Diluted EPS	-	-	-	-1.00	-	-	-	-	-	-	-
Basic Shares Outstanding	8.07	8.13	8.13	8.29	8.47	8.47	8.14	7.54	8.41	7.46	7.06
Diluted Shares Outstanding	8.07	8.21	8.21	8.29	8.48	8.48	8.36	8.14	8.41	7.46	7.65

Source: Company financial statements from annual and quarterly filings. Data as of Aug 31, 2026. Data sources and methodology

Frequently Asked Questions About Cryo-Cell International Financial Statements

What was Cryo-Cell International's revenue in fiscal 2025?

Cryo-Cell International reported revenue of $31.57M in fiscal 2025 (fiscal year ended Nov 30, 2025). That was down 1.3% from $31.99M a year earlier.

Is Cryo-Cell International profitable?

No. Cryo-Cell International reported a net loss of $2.43M in fiscal 2025. In fiscal 2024 it earned $402.10K.

What is Cryo-Cell International's operating margin?

Cryo-Cell International's operating income was $4.84M on revenue of $31.57M in fiscal 2025, an operating margin of 15.3%, compared with 10.9% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition